Your browser doesn't support javascript.
loading
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma.
Sun, Weijing; Patel, Anuj; Normolle, Daniel; Patel, Krishna; Ohr, James; Lee, James J; Bahary, Nathan; Chu, Edward; Streeter, Natalie; Drummond, Summer.
Afiliação
  • Sun W; University of Kansas School of Medicine, Westwood, Kansas.
  • Patel A; University of Kansas Cancer Center, Westwood, Kansas.
  • Normolle D; Division of Hematology-Oncology, Department of Medicine, Harvard University and Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Patel K; Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
  • Ohr J; Texas Oncology, Round Rock, Texas.
  • Lee JJ; University of Pittsburgh School of Medicine and Hillman Cancer Center at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Bahary N; University of Pittsburgh School of Medicine and Hillman Cancer Center at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Chu E; University of Pittsburgh School of Medicine and Hillman Cancer Center at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Streeter N; University of Pittsburgh School of Medicine and Hillman Cancer Center at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Drummond S; University of Kansas Cancer Center, Westwood, Kansas.
Cancer ; 125(6): 902-909, 2019 03 15.
Article em En | MEDLINE | ID: mdl-30561756

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias do Sistema Biliar / Adenocarcinoma / Inibidores da Angiogênese / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias do Sistema Biliar / Adenocarcinoma / Inibidores da Angiogênese / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article